|
Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma |
|
|
|
Title: |
Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma |
Author: |
Gopal, A.K. Fanale, M.A. Moskowitz, C.H. Shustov, A.R. Mitra, S. Ye, W. Younes, A. Moskowitz, A.J. |
Appeared in: |
Annals of oncology |
Paging: |
Volume 28 () nr. 5 pages 1057-1063 |
Year: |
2017 |
Contents: |
|
Publisher: |
European Society for Medical Oncology |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|